CannLabs Inc (CANL)
0.00
USD |
OTCM |
Jun 03, 16:00
CannLabs Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 03, 2024 | 0.00 |
| May 31, 2024 | 0.00 |
| May 30, 2024 | 0.00 |
| May 29, 2024 | 0.00 |
| May 28, 2024 | 0.00 |
| May 24, 2024 | 0.00 |
| May 23, 2024 | 0.00 |
| May 22, 2024 | 0.00 |
| May 21, 2024 | 0.00 |
| May 20, 2024 | 0.00 |
| May 17, 2024 | 0.00 |
| May 16, 2024 | 0.00 |
| May 15, 2024 | 0.00 |
| May 14, 2024 | 0.00 |
| May 13, 2024 | 0.00 |
| May 10, 2024 | 0.00 |
| May 09, 2024 | 0.00 |
| May 08, 2024 | 0.1398 |
| May 07, 2024 | 0.1398 |
| May 06, 2024 | 0.1398 |
| May 03, 2024 | 0.1398 |
| May 02, 2024 | 0.1398 |
| May 01, 2024 | 0.1398 |
| April 30, 2024 | 0.1398 |
| April 29, 2024 | 0.1398 |
| Date | Value |
|---|---|
| April 26, 2024 | 0.1398 |
| April 25, 2024 | 0.1398 |
| April 24, 2024 | 0.1398 |
| April 23, 2024 | 0.1398 |
| April 22, 2024 | 0.1398 |
| April 19, 2024 | 0.1398 |
| April 18, 2024 | 0.1398 |
| April 17, 2024 | 0.1398 |
| April 16, 2024 | 0.1398 |
| April 15, 2024 | 0.1398 |
| April 12, 2024 | 0.1398 |
| April 11, 2024 | 0.1398 |
| April 10, 2024 | 0.1398 |
| April 09, 2024 | 0.1398 |
| April 08, 2024 | 0.1398 |
| April 05, 2024 | 0.1398 |
| April 04, 2024 | 0.1398 |
| April 03, 2024 | 0.1398 |
| April 02, 2024 | 0.1398 |
| April 01, 2024 | 0.1398 |
| March 28, 2024 | 0.1398 |
| March 27, 2024 | 0.1398 |
| March 26, 2024 | 0.1398 |
| March 25, 2024 | 0.1398 |
| March 22, 2024 | 0.1398 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
Dec 15 2023
43.20
Maximum
Feb 11 2021
5.397
Average
4.244
Median
Dec 31 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 4.376 |
| Perspective Therapeutics Inc | 3.710 |
| Protalix BioTherapeutics Inc | 2.831 |
| Electromed Inc | 2.972 |
| Armata Pharmaceuticals Inc | -- |